OncoSil Medical Limited (ASX:OSL)
0.0040
0.00 (0.00%)
Apr 4, 2025, 3:36 PM AEST
OncoSil Medical Revenue
OncoSil Medical had revenue of 985.38K AUD in the half year ending December 31, 2024, with 21.71% growth. This brings the company's revenue in the last twelve months to 1.91M, up 47.09% year-over-year. In the fiscal year ending June 30, 2024, OncoSil Medical had annual revenue of 1.57M with 6.68% growth.
Revenue (ttm)
1.91M
Revenue Growth
+47.09%
P/S Ratio
6.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
18.43M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 1.57M | 97.96K | 6.68% |
Jun 30, 2023 | 1.47M | 404.03K | 38.00% |
Jun 30, 2022 | 1.06M | -234.94K | -18.10% |
Jun 30, 2021 | 1.30M | -1.47M | -53.02% |
Jun 30, 2020 | 2.76M | -862.28K | -23.78% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Mesoblast | 9.16M |